Document is current
Any future updates will be listed below
-
Authors
Munera-Campos, Mónica https://orcid.org/0000-0002-2227-2993
Carrascosa, Jose Manuel https://orcid.org/0000-0003-4266-0771
- License Information
-
More Information
Article History
Accepted: 9 October 2023
First Online: 30 October 2023
Declarations
:
: The authors received no funding for this manuscript.
: M. Munera-Campos has received fees for scientific advisory, presentations, and other related activities from AbbVie, LEO Pharma, Janssen, Sanofi, and Galderma. She has also participated as a principal investigator and sub-investigator in clinical trials for Lilly, LEO Pharma, Novartis, Janssen, Sanofi, Pfizer, AbbVie, Almirall, UCB, and Galderma. J.M. Carrascosa has participated as a principal investigator/sub-investigator and has received fees as a speaker or as a member of the expert steering committee for AbbVie, Novartis, Janssen, Lilly, Sandoz, Amgen, Almirall, BMS, Boehringer Ingelheim, Biogen, LEO Pharma, and UCB.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: MM-C and JMC have equally participated in the critical literature review and the writing of this manuscript. All authors have read and approved the final manuscript.
